Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Neurosci
2005 Dec 07;2549:11313-21. doi: 10.1523/JNEUROSCI.3711-05.2005.
Show Gene links
Show Anatomy links
Beta-secretase-cleaved amyloid precursor protein accumulates at actin inclusions induced in neurons by stress or amyloid beta: a feedforward mechanism for Alzheimer's disease.
Maloney MT
,
Minamide LS
,
Kinley AW
,
Boyle JA
,
Bamburg JR
.
???displayArticle.abstract???
Rod-like inclusions (rods), composed of actin saturated with actin depolymerizing factor (ADF)/cofilin, are induced in hippocampal neurons by ATP depletion, oxidative stress, and excess glutamate and occur in close proximity to senile plaques in human Alzheimer's disease (AD) brain (Minamide et al., 2000). Here, we show rods are found in brains from transgenic AD mice. Soluble forms of amyloid beta (Abeta(1-42)) induce the formation of rods in a maximum of 19% of cultured hippocampal neurons in a time- and concentration-dependent manner. Approximately one-half of the responding neurons develop rods within 6 h or with as little as 10 nM Abeta(1-42). Abeta(1-42) induces the activation (dephosphorylation) of ADF/cofilin in neurons that form rods. Vesicles containing amyloid precursor protein (APP), beta-amyloid cleavage enzyme, and presenilin-1, a component of the gamma-secretase complex, accumulate at rods. The beta-secretase-cleaved APP (either beta-C-terminal fragment of APP or Abeta) also accumulates at rods. These results suggest that rods, formed in response to either Abeta or some other stress, block the transport of APP and enzymes involved in its processing to Abeta. These stalled vesicles may provide a site for producing Abeta(1-42), which may in turn induce more rods in surrounding neurons, and expand the degenerative zone resulting in plaque formation.
Abe,
A cofilin-like protein is involved in the regulation of actin assembly in developing skeletal muscle.
1989, Pubmed
Abe,
A cofilin-like protein is involved in the regulation of actin assembly in developing skeletal muscle.
1989,
Pubmed
Anandatheerthavarada,
Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells.
2003,
Pubmed
Bahr,
Amyloid beta protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein.
1998,
Pubmed
Bamburg,
ADF/cofilin and actin dynamics in disease.
2002,
Pubmed
Bartlett,
An electron microscopic study of the development of axons and dendrites by hippocampal neurons in culture. I. Cells which develop without intercellular contacts.
1984,
Pubmed
Bernstein,
Actin-ATP hydrolysis is a major energy drain for neurons.
2003,
Pubmed
Blennow,
CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease.
2001,
Pubmed
Bruijn,
ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.
1997,
Pubmed
Café,
Oxidative stress after acute and chronic application of beta-amyloid fragment 25-35 in cortical cultures.
1996,
Pubmed
Chartier-Harlin,
Screening for the beta-amyloid precursor protein mutation (APP717: Val----Ile) in extended pedigrees with early onset Alzheimer's disease.
1991,
Pubmed
Chartier-Harlin,
Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene.
1991,
Pubmed
Chromy,
Self-assembly of Abeta(1-42) into globular neurotoxins.
2003,
Pubmed
Cleary,
Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function.
2005,
Pubmed
Cordy,
Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein.
2003,
Pubmed
Dahlgren,
Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.
2002,
Pubmed
Ehehalt,
Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts.
2003,
Pubmed
Friedman,
Neurotrophins induce death of hippocampal neurons via the p75 receptor.
2000,
Pubmed
Goate,
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.
1991,
Pubmed
Gong,
Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss.
2003,
Pubmed
Grace,
Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease.
2002,
Pubmed
Grant,
Mitochondrial abnormalities in neuroectodermal cells stably expressing human amyloid precursor protein (hAPP751).
1999,
Pubmed
Hardy,
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
2002,
Pubmed
Harris,
Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons.
1995,
Pubmed
Hartley,
Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons.
1999,
Pubmed
Head,
Down syndrome and beta-amyloid deposition.
2004,
Pubmed
Hensley,
Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated amyloid beta peptide.
1996,
Pubmed
Hirano,
Hirano bodies and related neuronal inclusions.
1994,
Pubmed
Hiruma,
Glutamate and amyloid beta-protein rapidly inhibit fast axonal transport in cultured rat hippocampal neurons by different mechanisms.
2003,
Pubmed
Hsiao,
Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.
1996,
Pubmed
Kim,
Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein.
2003,
Pubmed
Koo,
Evidence that production and release of amyloid beta-protein involves the endocytic pathway.
1994,
Pubmed
Lacor,
Synaptic targeting by Alzheimer's-related amyloid beta oligomers.
2004,
Pubmed
Lambert,
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.
1998,
Pubmed
Lim,
A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.
2005,
Pubmed
Lustbader,
ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.
2004,
Pubmed
Maciver,
Two actin binding proteins, actin depolymerizing factor and cofilin, are associated with Hirano bodies.
1995,
Pubmed
Mattson,
Pathways towards and away from Alzheimer's disease.
2004,
Pubmed
Mattson,
Isolated hippocampal neurons in cryopreserved long-term cultures: development of neuroarchitecture and sensitivity to NMDA.
1988,
Pubmed
McLean,
Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.
1999,
Pubmed
Meberg,
Increase in neurite outgrowth mediated by overexpression of actin depolymerizing factor.
2000,
Pubmed
,
Xenbase
Meberg,
Culturing hippocampal and cortical neurons.
2003,
Pubmed
Meberg,
Actin depolymerizing factor and cofilin phosphorylation dynamics: response to signals that regulate neurite extension.
1998,
Pubmed
Minamide,
Neurodegenerative stimuli induce persistent ADF/cofilin-actin rods that disrupt distal neurite function.
2000,
Pubmed
Murrell,
A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease.
1991,
Pubmed
Nixon,
Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases.
2005,
Pubmed
Perini,
Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokines.
2002,
Pubmed
Pike,
beta-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology.
1992,
Pubmed
Price,
Amyloid beta amyloidosis in Alzheimer's disease.
1995,
Pubmed
Sisodia,
Role of the beta-amyloid protein in Alzheimer's disease.
1995,
Pubmed
Stine,
In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis.
2003,
Pubmed
Stokin,
Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease.
2005,
Pubmed
Takahashi,
Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain.
2004,
Pubmed
Tanzi,
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.
2005,
Pubmed
Walsh,
Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.
1999,
Pubmed
Walsh,
Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.
2002,
Pubmed
Walsh,
Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition.
2002,
Pubmed
Yamazaki,
Trafficking of cell surface beta-amyloid precursor protein: retrograde and transcytotic transport in cultured neurons.
1995,
Pubmed
Yamazaki,
Trafficking of cell-surface amyloid beta-protein precursor. II. Endocytosis, recycling and lysosomal targeting detected by immunolocalization.
1996,
Pubmed
Ye,
Amyloid beta-protein induced electrophysiological changes are dependent on aggregation state: N-methyl-D-aspartate (NMDA) versus non-NMDA receptor/channel activation.
2004,
Pubmed
